LONGBOARD PHARMACEUTICALS IN's ticker is LBPH and the CUSIP is 54300N103. A total of 51 filers reported holding LONGBOARD PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,321,403 | $20,869,000 | 0.71% |
| Integral Health Asset Management, LLC | 30,000 | $274,000 | 0.08% |
| FARALLON CAPITAL MANAGEMENT LLC | 810,500 | $7,392,000 | 0.03% |
| Orbimed Advisors | 113,500 | $1,035,000 | 0.01% |
| Alyeska Investment Group, L.P. | 85,360 | $778,000 | 0.01% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2,287,289 | $20,105,000 | 0.00% |
| Laurion Capital Management LP | 20,918 | $191,000 | 0.00% |
| FMR LLC | 2,037,831 | $18,585,000 | 0.00% |
| BlackRock Inc. | 17,999 | $164,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 38 | $0 | 0.00% |